Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

891456

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Health Care: Data Protection
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the General Data Protection Regulation on (a) pharmacists, (b) dentists, (c) optometrists, (d) general practitioners and (e) other NHS primary care contractors.
tabling member constituency	Burnley
tabling member printed	Julie Cooper
uin	138068
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>It is the responsibility of each organisation to ensure their compliance with the General Data Protection Regulation which comes into effect on 25 May 2018. For the past year we have been working alongside system partners across health and social care in developing a comprehensive suite of guidance products to help organisations recognise their obligations and help put effective governance and risk management arrangements in place from 25 May. These guidance materials are available to all health and care organisations on the NHS Digital website and will include guidance to general practice, optometry, pharmaceutical and dental organisations. In addition, there is considerable information and guidance available from the Information Commissioner’s Office.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 138069 question first answered 03/05/2018 13:03:40 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4405 label Biography information for Julie Cooper

891458

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Health Care: Data Protection
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the quantum of associated costs of implementing the General Data Protection Regulation for (a) pharmacists, (b) dentists, (c) optometrists, (d) general practitioners and (e) other NHS primary care contractors.
tabling member constituency	Burnley
tabling member printed	Julie Cooper
uin	138069
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>It is the responsibility of each organisation to ensure their compliance with the General Data Protection Regulation which comes into effect on 25 May 2018. For the past year we have been working alongside system partners across health and social care in developing a comprehensive suite of guidance products to help organisations recognise their obligations and help put effective governance and risk management arrangements in place from 25 May. These guidance materials are available to all health and care organisations on the NHS Digital website and will include guidance to general practice, optometry, pharmaceutical and dental organisations. In addition, there is considerable information and guidance available from the Information Commissioner’s Office.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 138068 question first answered 03/05/2018 13:03:40 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4405 label Biography information for Julie Cooper

891482

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Sodium Valproate
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations his Department and its agencies have received on the resources necessary to improve patient safety and engage with health professionals to raise awareness of the potential health risks for women of child-bearing age taking Sodium Valproate; and if he will make a statement.
tabling member constituency	Chesham and Amersham
tabling member printed	Dame Cheryl Gillan
uin	137887
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is working in partnership with the Department, professional bodies and the healthcare system to deliver a package of measures to raise awareness of the significant risks associated with sodium valproate in pregnancy and to support healthcare professionals in reducing the harms from valproate in women of child-bearing age and improving patient safety in line with the strengthened regulatory position. Educational materials for healthcare professionals and patients are being sent to general practitioners (GP) and specialist prescribers. The National Institute for Health and Care Excellence has updated its guidelines which mention valproate to reflect the new regulatory measures. GP electronic system providers have provided a search and audit function to facilitate the identification of women of childbearing age on valproate and are updating the alerts for valproate.</p><p> </p><p>All parties involved are fully committed to this important work using the resources available from each relevant organisation. In addition, since 2016 the MHRA has been working with a network of over 40 stakeholder organisations (termed the Valproate Stakeholders’ Network) to foster cross-sector support for the new measures and leverage their collective communications reach.</p><p> </p><p>The effectiveness of the new measures in reducing prescribing of valproate in women of childbearing potential will be closely monitored. Relevant data will be published and there will be ongoing follow-up to ensure that the harms to the child from valproate in pregnancy are minimised.</p><p> </p><p>I would particularly like to thank the families involved in the Valproate Stakeholder Network who have shared their experiences and expertise. Their dedication, support and altruism will help to keep future generations of children safe.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 03/05/2018 12:59:46 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	18 label Biography information for Dame Cheryl Gillan

891505

registered interest
date	25/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the introduction of an outcomes-based payment approach for (a) manufacturers and (b) providers of (i) medical devices, (ii) medical diagnostics, and (iii) health apps; and if he will make a statement.
tabling member constituency	Shipley
tabling member printed	Philip Davies
uin	138012
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>A fee-for-service payment system, where each individual element of care is charged for separately, does not operate in the National Health Service in England. Generally, acute services are paid for on the basis of complete spells in hospital. With the exception of some high cost drugs and devices, this includes the costs of all devices, diagnostics and any other costs associated with the care whilst in hospital.</p><p> </p><p>NHS England is exploring new ways of managing payment for health apps, including a consideration of outcome based payment models.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 03/05/2018 13:00:51 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1565 label Biography information for Sir Philip Davies